Report date: Jan 19,2021
Conflict count: 312398
Publisher: American Society for Pharmacology & Experimental Therapeutics
Title count: 4
Conflict count: 12


==========================================================

Created: 2019-09-11 16:29:57.0
ConfID: 5525794
CauseID: 1453829689
OtherID: 98544698
JT: Drug Metabolism and Disposition
MD: Ishii, 32 ,10,1057,2004,SIMULTANEOUS EXPRESSION OF GUINEA PIG UDP-GLUCURONOSYLTRANSFERASE 2B21 (UGT2B21) AND 2B22 IN COS-7 CELLS ENHANCES UGT2B21-CATALYZED CHLORAMPHENICOL GLUCURONIDATION
DOI: 10.1124/dmd.32.10.(Journal) (5525794-N )
DOI: 10.1124/dmd.32.10.1057(Journal)
==========================================================

Created: 2019-09-11 16:30:04.0
ConfID: 5525795
CauseID: 1453829691
OtherID: 108432327
JT: Drug Metabolism and Disposition
MD: Cui, 32 ,11,1260,2004,HETEROTROPIC MODULATION OF SULFOTRANSFERASE 2A1 ACTIVITY BY CELECOXIB: PRODUCT RATIO SWITCHING OF ETHYNYLESTRADIOL SULFATION
DOI: 10.1124/dmd.32.11.(Journal) (5525795-N )
DOI: 10.1124/dmd.32.11.1260(Journal)
==========================================================

Created: 2019-09-11 16:30:12.0
ConfID: 5525796
CauseID: 1453829693
OtherID: 122034425
JT: Drug Metabolism and Disposition
MD: Nicoll-Griffith, 32 ,12,1509,2004,USE OF A BENZYLOXY-SUBSTITUTED LACTONE CYCLOOXYGENASE-2 INHIBITOR AS A SELECTIVE FLUORESCENT PROBE FOR CYP3A ACTIVITY IN PRIMARY CULTURED RAT AND HUMAN HEPATOCYTES
DOI: 10.1124/dmd.32.12.(Journal) (5525796-N )
DOI: 10.1124/dmd.32.12.1509(Journal)
==========================================================

Created: 2019-09-11 16:30:04.0
ConfID: 5525797
CauseID: 1453829691
OtherID: 108432327
JT: Drug Metabolism and Disposition
MD: Silva, 32 ,11,1304,2004,VALPROYL-DEPHOSPHOCoA: A NOVEL METABOLITE OF VALPROATE FORMED IN VITRO IN RAT LIVER MITOCHONDRIA
DOI: 10.1124/dmd...(Journal) (5525797-N )
DOI: 10.1124/dmd.32.11.1304(Journal)